Lifestance Health Group, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
TPG GP A, LLC, along with James G. Coulter and Jon Winkelried, have jointly filed an amendment to Schedule 13G, reporting a combined beneficial ownership of 98,101,407 shares of LifeStance Health Group, Inc. common stock, representing 25.7% of the outstanding shares.
NASDAQ
Summit Partners, through various affiliated entities, has updated its beneficial ownership filing for LifeStance Health Group, Inc., reporting a combined 6.10% stake.
NASDAQ
TPG GP A, LLC and its principals report a 29.3% beneficial ownership stake in LifeStance Health Group, Inc. via an amended Schedule 13G filing.
NASDAQ
Summit Partners and its affiliated entities have filed an amendment to their Schedule 13G, disclosing a 7.49% beneficial ownership in LifeStance Health Group, Inc.
NASDAQ
FMR LLC and its affiliates, including Abigail P. Johnson, reported a 12.0% beneficial ownership stake in LifeStance Health Group Inc. common stock as of December 31, 2025.
NASDAQ
Summit Partners and its affiliated entities have filed an amended Schedule 13G, reporting a collective beneficial ownership of 8.62% in LifeStance Health Group, Inc.
NASDAQ
FMR LLC and Abigail P. Johnson report a continued 10.1% beneficial ownership in LifeStance Health Group Inc. common stock.
NASDAQ
FMR LLC and Abigail P. Johnson report continued beneficial ownership of 10.0% of LifeStance Health Group Inc.'s common stock as of September 30, 2025.
NASDAQ
SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 8.6% Passive Stake in LifeStance Health Group
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a passive beneficial ownership of 8.6% in LifeStance Health Group Inc. as of December 31, 2024.